Two cisplatin-resistant NSCLC cell lines display MET overexpression and increased expression of N-cadherin, vimentin, ZEB1 and Snail and reduced expression of E-cadherin compared to their isogenic parental cells [31]. This evidence concerns the gene MET and non-small cell lung carcinoma.